UA71920C2 - Two-part capsule for receiving pharmaceutical preparations for powder inhalers - Google Patents
Two-part capsule for receiving pharmaceutical preparations for powder inhalers Download PDFInfo
- Publication number
- UA71920C2 UA71920C2 UA2001031523A UA2001031523A UA71920C2 UA 71920 C2 UA71920 C2 UA 71920C2 UA 2001031523 A UA2001031523 A UA 2001031523A UA 2001031523 A UA2001031523 A UA 2001031523A UA 71920 C2 UA71920 C2 UA 71920C2
- Authority
- UA
- Ukraine
- Prior art keywords
- capsule
- lid
- capsule according
- differs
- fact
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 169
- 239000000843 powder Substances 0.000 title claims abstract description 24
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 7
- 239000004033 plastic Substances 0.000 claims abstract description 14
- 229920003023 plastic Polymers 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 3
- 230000008719 thickening Effects 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 14
- -1 polyethylene Polymers 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 230000035699 permeability Effects 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 229920001903 high density polyethylene Polymers 0.000 claims description 3
- 239000004700 high-density polyethylene Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims description 2
- 238000004026 adhesive bonding Methods 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 238000003466 welding Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 108010010803 Gelatin Proteins 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960004618 prednisone Drugs 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920003134 Eudragit® polymer Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical class O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960003060 bambuterol Drugs 0.000 description 1
- ANZXOIAKUNOVQU-UHFFFAOYSA-N bambuterol Chemical compound CN(C)C(=O)OC1=CC(OC(=O)N(C)C)=CC(C(O)CNC(C)(C)C)=C1 ANZXOIAKUNOVQU-UHFFFAOYSA-N 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010102 injection blow moulding Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- IQSHMXAZFHORGY-UHFFFAOYSA-N methyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound COC(=O)C=C.CC(=C)C(O)=O IQSHMXAZFHORGY-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229960000257 tiotropium bromide Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/072—Sealing capsules, e.g. rendering them tamper-proof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19835346A DE19835346A1 (de) | 1998-08-05 | 1998-08-05 | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| PCT/EP1999/005614 WO2000007572A2 (de) | 1998-08-05 | 1999-08-03 | Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA71920C2 true UA71920C2 (en) | 2005-01-17 |
Family
ID=7876530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001031523A UA71920C2 (en) | 1998-08-05 | 1999-03-08 | Two-part capsule for receiving pharmaceutical preparations for powder inhalers |
Country Status (35)
| Country | Link |
|---|---|
| US (3) | US20010008637A1 (da) |
| EP (1) | EP1100474B1 (da) |
| JP (1) | JP2002522378A (da) |
| KR (1) | KR100622291B1 (da) |
| CN (1) | CN1151779C (da) |
| AR (1) | AR023640A1 (da) |
| AT (1) | ATE220542T1 (da) |
| AU (1) | AU763266B2 (da) |
| BG (1) | BG64115B1 (da) |
| BR (1) | BR9912748A (da) |
| CA (1) | CA2338323C (da) |
| CZ (1) | CZ301558B6 (da) |
| DE (2) | DE19835346A1 (da) |
| DK (1) | DK1100474T5 (da) |
| EA (1) | EA002186B1 (da) |
| EE (1) | EE04451B1 (da) |
| ES (1) | ES2180325T3 (da) |
| HK (1) | HK1037975A1 (da) |
| HU (1) | HU224955B1 (da) |
| ID (1) | ID28290A (da) |
| IL (2) | IL141124A0 (da) |
| MY (1) | MY117930A (da) |
| NO (1) | NO329078B1 (da) |
| NZ (1) | NZ509977A (da) |
| PL (1) | PL191231B1 (da) |
| PT (1) | PT1100474E (da) |
| SI (1) | SI1100474T1 (da) |
| SK (1) | SK283568B6 (da) |
| TR (1) | TR200100355T2 (da) |
| TW (1) | TWI221420B (da) |
| UA (1) | UA71920C2 (da) |
| UY (1) | UY25637A1 (da) |
| WO (1) | WO2000007572A2 (da) |
| YU (1) | YU49388B (da) |
| ZA (1) | ZA200100796B (da) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19835346A1 (de) | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
| CA2391707C (en) * | 1999-07-30 | 2010-05-11 | Smithkline Beecham Plc | Multi-component pharmaceutical dosage form |
| AU2002210575A1 (en) * | 2000-10-31 | 2002-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel medicament compositions based on anticholinergics and corticosteroids |
| US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| DE10063957A1 (de) * | 2000-12-20 | 2002-06-27 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
| GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| US20050175687A1 (en) * | 2001-01-30 | 2005-08-11 | Mcallister Stephen M. | Pharmaceutical formulations |
| US7883721B2 (en) | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
| US7842308B2 (en) * | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030070679A1 (en) * | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
| DE10126924A1 (de) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
| DE10137054A1 (de) * | 2001-07-28 | 2003-02-13 | Boehringer Ingelheim Pharma | Verfahren zum Verschweißen von medizinischen Kapseln für die Inhalation, Inhalationskapseln und Apparat zum Verschweißen |
| US6949154B2 (en) | 2001-07-28 | 2005-09-27 | Boehringer Ingelheim Pharma Kg | Method and apparatus for sealing medicinal capsules |
| GB0122031D0 (en) * | 2001-09-12 | 2001-10-31 | Pfizer Ltd | Use of pde4 inhibitors in a dry powder inhaler |
| US6941980B2 (en) | 2002-06-27 | 2005-09-13 | Nektar Therapeutics | Apparatus and method for filling a receptacle with powder |
| US20040043064A1 (en) * | 2002-08-29 | 2004-03-04 | Iorio Theodore L. | Dosage forms having reduced moisture transmission |
| US7699052B2 (en) | 2002-09-05 | 2010-04-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Apparatus for the dispensing of liquids, container cartridge suitable for this, and system comprising the apparatus for the dispensing of liquids, and the container cartridge |
| US7763280B2 (en) * | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
| US7516741B2 (en) | 2002-12-06 | 2009-04-14 | Novartis Ag | Aerosolization apparatus with feedback mechanism |
| US7284553B2 (en) | 2002-12-12 | 2007-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
| DE10258360A1 (de) * | 2002-12-12 | 2004-06-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel |
| MXPA05007156A (es) * | 2002-12-31 | 2005-09-21 | Nektar Therapeutics | Formulacion farmaceuticas aerosolizable para terapia para infecciones fungicas. |
| US7669596B2 (en) | 2002-12-31 | 2010-03-02 | Novartis Pharma Ag | Aerosolization apparatus with rotating capsule |
| US7878193B2 (en) | 2003-01-14 | 2011-02-01 | Boehringer Ingelheim International Gmbh | Capsule for taking an active substance which can be inhaled |
| DE10300984A1 (de) * | 2003-01-14 | 2004-07-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Kapsel zur Aufnahme eines inhalativ applizierbaren Wirkstoffs |
| PL1610850T3 (pl) | 2003-04-09 | 2012-11-30 | Novartis Ag | Urządzenie rozpylające z osłoną wlotu powietrza |
| US8869794B1 (en) | 2003-04-09 | 2014-10-28 | Novartis Pharma Ag | Aerosolization apparatus with capsule puncturing member |
| PL1615689T3 (pl) | 2003-04-09 | 2016-06-30 | Novartis Ag | Urządzenie do aerozolizacji z prowadnicą wyrównującą do przebijania kapsułki |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
| PE20060003A1 (es) * | 2004-03-12 | 2006-03-01 | Smithkline Beecham Plc | Formulacion farmaceutica polimerica para moldear por inyeccion |
| DE102004012973B4 (de) * | 2004-03-17 | 2006-03-23 | Josef Eckert | Kapsel zur Aufnahme wenigstens einer pharmazeutischen Zubereitung, insbesondere für Pulverinhalatoren, sowie Kapselkette bestehend aus mehreren solcher Kapseln |
| US8513204B2 (en) | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
| JP2008503586A (ja) | 2004-06-21 | 2008-02-07 | ネクター セラピューティクス | アンフォテリシンｂを含む組成物、方法、およびシステム |
| WO2006031712A2 (en) | 2004-09-13 | 2006-03-23 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
| DE102005001332A1 (de) | 2005-01-11 | 2006-07-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| DE102005022862A1 (de) * | 2005-05-18 | 2006-12-14 | Airsec S.A.S | Kapseln für Inhalatoren |
| US8377471B2 (en) * | 2005-08-09 | 2013-02-19 | Capsugel Belgium Nv | Container |
| DE102005054383B4 (de) * | 2005-11-15 | 2013-10-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Nadel zum Lochen von Pulverkapseln für die Inhalation |
| NL1033047C2 (nl) * | 2006-12-13 | 2008-06-16 | Pharmachemie Bv | Capsule, gevuld met een medicijn, in het bijzonder een inhaleerbaar medicijn. |
| DE102007036411A1 (de) | 2007-07-20 | 2009-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
| DE102007033861A1 (de) | 2007-07-20 | 2009-07-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
| EP2209455A1 (en) * | 2007-10-15 | 2010-07-28 | Glaxo Group Limited | Paneled capsule shells for release of pharmaceutical compositions |
| WO2009050193A1 (en) * | 2007-10-15 | 2009-04-23 | Glaxo Group Limited | Method and apparatus for manufacturing filled linkers |
| CN101827571A (zh) * | 2007-10-15 | 2010-09-08 | 葛兰素集团有限公司 | 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型 |
| ATE555768T1 (de) | 2007-10-19 | 2012-05-15 | Capsugel Belgium Nv | Behälter mit mehreren fächern |
| DE102007052871A1 (de) | 2007-11-02 | 2009-05-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen |
| DE102007058112A1 (de) | 2007-12-03 | 2009-06-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator mit Wirkstofftablette |
| RU2487730C2 (ru) * | 2007-12-05 | 2013-07-20 | Новартис Аг | Емкость для лекарственного средства аэрозольного применения |
| AU2009246217B2 (en) | 2008-05-15 | 2013-01-10 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| AU2009256572A1 (en) * | 2008-06-13 | 2009-12-17 | Capsugel Belgium Nv | Hydroxypropyl cellulose capsule shell |
| US8298616B2 (en) * | 2008-07-24 | 2012-10-30 | American Air Liquide, Inc. | Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films |
| EP2350118B1 (en) | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| AT507631B1 (de) * | 2008-11-26 | 2012-05-15 | Haas Rouven Mag | Vorrichtung zum ansaugen von pulver- oder granulat-material und kapsel hierfür |
| JP2012520890A (ja) | 2009-03-18 | 2012-09-10 | インカーダ セラピューティクス， インコーポレイテッド | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| US8746244B2 (en) | 2009-10-02 | 2014-06-10 | Boehringer Ingelheim International Gmbh | Powder inhaler |
| US8834931B2 (en) | 2009-12-25 | 2014-09-16 | Mahmut Bilgic | Dry powder formulation containing tiotropium for inhalation |
| TR200909790A2 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu. |
| DE102010002604A1 (de) * | 2010-03-05 | 2011-09-08 | Robert Bosch Gmbh | Kapsel zur Aufnahme eines Mediums und Verfahren zur Herstellung der Kapsel |
| WO2013174752A2 (de) | 2012-05-21 | 2013-11-28 | Boehringer Ingelheim International Gmbh | System aus inhalator und kapsel |
| JP6037315B2 (ja) * | 2011-05-27 | 2016-12-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 吸入器及び吸入器用カプセル |
| EP2614848B1 (de) | 2012-01-13 | 2020-07-01 | Boehringer Ingelheim International GmbH | Inhalator und Kapsel für einen Inhalator |
| DE202011102694U1 (de) | 2011-06-29 | 2011-12-19 | Zisser Gmbh | Inhalationsgerät für Heimanwender |
| PL2852423T3 (pl) * | 2012-05-21 | 2019-03-29 | Boehringer Ingelheim International Gmbh | System z inhalatora i kapsułki |
| US11992604B2 (en) * | 2014-11-09 | 2024-05-28 | Sipnose Ltd. | Devices and methods for delivering a substance to a body cavity |
| WO2016014153A1 (en) * | 2014-07-23 | 2016-01-28 | Microdose Therapeutx, Inc. | Dry powder nebulizer |
| DE102015108931B3 (de) * | 2015-06-05 | 2016-06-09 | Gerresheimer Regensburg Gmbh | Gitterelement für einen Inhalator |
| DE102015109996B3 (de) | 2015-06-22 | 2016-07-28 | Gerresheimer Regensburg Gmbh | Einrichtung zum Öffnen von Kapseln |
| KR101748796B1 (ko) | 2015-09-30 | 2017-06-19 | 한미약품 주식회사 | 활성성분의 전달량이 향상된 흡입용 캡슐제 |
| IL260335B2 (en) | 2016-02-01 | 2023-10-01 | Incarda Therapeutics Inc | Combining electronic monitoring with inhaled pharmacological therapy for the management of cardiac arrhythmia including atrial fibrillation |
| EP3419708B1 (de) | 2016-02-24 | 2019-11-20 | Boehringer Ingelheim International GmbH | Inhalator |
| EP3419707B1 (de) | 2016-02-24 | 2023-01-25 | Boehringer Ingelheim International GmbH | Inhalator |
| US10729619B2 (en) * | 2017-05-03 | 2020-08-04 | Garry Tsaur | Capsule sealing composition and its sealing method thereof |
| AU2018266199A1 (en) | 2017-05-10 | 2019-11-07 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| CA3062103A1 (en) | 2017-08-15 | 2019-02-21 | Thomas Julius Borody | Compositions, devices and methods for treating autism |
| EP3768378A4 (en) | 2018-03-22 | 2021-11-17 | InCarda Therapeutics, Inc. | INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE |
| US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| CN113933237B (zh) * | 2021-10-20 | 2023-10-13 | 山西信谊通制药有限公司 | 一种阿莫西林胶囊检测装置 |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US596591A (en) * | 1898-01-04 | Track device for operating signals | ||
| GB691696A (en) | 1950-10-05 | 1953-05-20 | Becton Dickinson Co | Improvements relating to hypodermic injection apparatus |
| US2718980A (en) * | 1951-10-02 | 1955-09-27 | Robinson William H | Container seal |
| NL269886A (da) * | 1960-10-04 | |||
| US3285408A (en) * | 1964-10-16 | 1966-11-15 | Lilly Co Eli | Capsule with integral locking band |
| US3623997A (en) * | 1966-06-06 | 1971-11-30 | Ncr Co | Wall-sealing treatment for minute capsules and minute capsules having walls of sealed polymeric material |
| US3949751A (en) * | 1970-03-03 | 1976-04-13 | Fisons Limited | Method and device for dispensing medicament to the body |
| US3664495A (en) * | 1970-12-21 | 1972-05-23 | Parke Davis & Co | Locking capsule |
| IT941426B (it) * | 1971-07-17 | 1973-03-01 | Isf Spa | Inalatore a camera di turbinio per sostanze medicamentose polveriformi |
| US3823843A (en) * | 1972-10-26 | 1974-07-16 | Lilly Co Eli | Locking capsule |
| US4069819A (en) * | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1016489B (it) * | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
| US4040536A (en) * | 1975-05-05 | 1977-08-09 | R. P. Scherer Corporation | Locking hard gelatin capsule |
| US4880547A (en) * | 1975-06-30 | 1989-11-14 | Kenji Etani | Methods for water treatment |
| US4692314A (en) * | 1975-06-30 | 1987-09-08 | Kenji Etani | Water treatment systems |
| JPS5352619A (en) | 1976-10-25 | 1978-05-13 | Shin Etsu Chem Co Ltd | Enteric capsule |
| GB1598081A (en) * | 1977-02-10 | 1981-09-16 | Allen & Hanburys Ltd | Inhaler device for dispensing medicaments |
| DE2722822C2 (de) * | 1977-05-20 | 1984-11-08 | Capsugel AG, Basel | Verfahren zum Herstellen einer zum Aufnehmen eines viskosen Stoffes, insbesondere eines flüssigen Arzneimittels, geeigneten Steckkapsel |
| US4192304A (en) * | 1978-03-14 | 1980-03-11 | Johnson & Johnson | Intravenous catheter assembly with fluid flow restriction capability |
| US4192309A (en) * | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
| BR8007911A (pt) * | 1979-12-06 | 1981-06-16 | Glaxo Group Ltd | Inalador aperfeicoado |
| CY1308A (en) * | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
| ES8206980A1 (es) * | 1980-10-30 | 1982-09-01 | Riker Laboratories Inc | Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo |
| GB2095497B (en) * | 1981-03-24 | 1984-08-15 | Racal Communications Equip | Improvements in and relating to direction finding |
| ATE27546T1 (de) * | 1982-10-29 | 1987-06-15 | Warner Lambert Co | Faelschungssichere kapseln. |
| US4656066A (en) * | 1982-12-20 | 1987-04-07 | Warner-Lambert Company | Apparatus and method for sealing capsules |
| US4533542A (en) * | 1983-08-22 | 1985-08-06 | Eli Lilly And Company | Pharmaceutical compositions for storage in plastic containers and process therefor |
| US4535567A (en) * | 1983-08-26 | 1985-08-20 | Seaborn Development, Inc. | Computer magnetic media burnisher |
| GB8325529D0 (en) * | 1983-09-23 | 1983-10-26 | Lilly Industries Ltd | Medicinal forms |
| US4738724A (en) * | 1983-11-04 | 1988-04-19 | Warner-Lambert Company | Method for forming pharmaceutical capsules from starch compositions |
| DE3345722A1 (de) * | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
| US4667498A (en) * | 1984-06-29 | 1987-05-26 | Sauter Manufacturing Corp. | Method and apparatus of making gelatine capsule forming pins having a rounded locking groove |
| US4883182A (en) * | 1985-05-31 | 1989-11-28 | Hughes Raymond J | Tamper evident capsule and insert device |
| US4648532A (en) * | 1986-05-09 | 1987-03-10 | Green Russell D | Mixing and discharge capsule |
| US4793493A (en) * | 1986-09-18 | 1988-12-27 | Makiej Jr Walter J | Multidose capsules |
| KR890003520Y1 (ko) * | 1986-12-20 | 1989-05-27 | 주식회사 서흥캅셀 | 의약용 캅셀 |
| GB8721455D0 (en) * | 1987-09-11 | 1987-10-21 | Lilly Industries Ltd | Capsules |
| US4863017A (en) * | 1988-11-09 | 1989-09-05 | Vlock D G | Amalgam capsule |
| US5342624A (en) * | 1989-02-16 | 1994-08-30 | British Technology Group Ltd. | Dispensing device |
| IT1228460B (it) * | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore monouso con capsula pre-forata |
| DE3927170A1 (de) * | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
| IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| JPH064531B2 (ja) * | 1990-06-04 | 1994-01-19 | アイセロ化学株式会社 | 大腸崩壊性硬質カプセル |
| PT100944B (pt) * | 1991-10-10 | 2000-02-29 | Alza Corp | Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos |
| US5417337A (en) * | 1991-11-12 | 1995-05-23 | Robbins, Iii; Edward S. | Reusable and re-collapsible container and associated cap |
| JPH0774149B2 (ja) | 1991-12-27 | 1995-08-09 | 藤本製薬株式会社 | 硬ゼラチンカプセル |
| US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
| US5388698A (en) * | 1992-02-03 | 1995-02-14 | Wakao; Hiroshi | Pocket carrier for dispensing products in precise quantitites |
| GB9223144D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Controlled release device |
| GB9223172D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule construction |
| EP0597136A1 (de) | 1992-11-08 | 1994-05-18 | Prenco Ag | Vorrichtung zum Abfördern und Reinigen von Lötrauch |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| US5396986A (en) * | 1993-06-16 | 1995-03-14 | Special Metals Corporation | Mixing capsule having three tubular members |
| US5498255A (en) * | 1993-08-17 | 1996-03-12 | Alza Corporation | Osmotic device for protracted pulsatile delivery of agent |
| JPH07118143A (ja) | 1993-10-18 | 1995-05-09 | Bayer Yakuhin Kk | ラグタイム制御型カプセル剤 |
| FR2715299B1 (fr) * | 1994-01-21 | 1996-06-14 | Georges Serge Grimberg | Médicament ayant une présentation pédiatrique facilitant son absorption par un enfant. |
| PT101450B (pt) * | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
| US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
| JP3455789B2 (ja) | 1995-02-28 | 2003-10-14 | 株式会社大塚製薬工場 | 複室容器用フィルム及び複室容器 |
| JP3028641U (ja) | 1995-09-23 | 1996-09-13 | スー ヘング カプセル カンパニー リミテッド | 薬品又は食品のカプセル |
| KR0124764Y1 (ko) * | 1995-09-23 | 1998-09-15 | 양주환 | 의약 및 식품용 하드 공 캅셀 |
| JPH09104060A (ja) | 1995-10-12 | 1997-04-22 | Sumitomo Bakelite Co Ltd | 医薬品包装用ポリプロピレン系シート及びその製造方法 |
| JPH09193963A (ja) | 1996-01-19 | 1997-07-29 | Material Eng Tech Lab Inc | 炭酸塩又は重炭酸塩を充填した樹脂容器の包装方法 |
| JP3328132B2 (ja) * | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | 吸入式投薬器 |
| PT101988B (pt) * | 1997-04-04 | 2004-02-27 | Hovione Farmaciencia Sa | Sistema de orientacao e posicionamento de um objecto |
| GB9805102D0 (en) * | 1998-03-10 | 1998-05-06 | Ciba Geigy Ag | Device |
| DE19835346A1 (de) | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| DE19961311A1 (de) * | 1999-12-18 | 2001-07-26 | Bayerische Motoren Werke Ag | Batteriesensorvorrichtung |
| US6949154B2 (en) * | 2001-07-28 | 2005-09-27 | Boehringer Ingelheim Pharma Kg | Method and apparatus for sealing medicinal capsules |
| JP3750994B2 (ja) * | 2001-11-16 | 2006-03-01 | 東京応化工業株式会社 | ポジ型ホトレジスト組成物および傾斜インプランテーションプロセス用薄膜レジストパターンの形成方法 |
| US8777011B2 (en) * | 2001-12-21 | 2014-07-15 | Novartis Ag | Capsule package with moisture barrier |
| US20030183548A1 (en) * | 2002-04-02 | 2003-10-02 | Oertel Fritz J. | Packing capsule |
| US20040025876A1 (en) * | 2002-05-07 | 2004-02-12 | Danforth Miller | Capsules for dry powder inhalers and methods of making and using same |
| US6941980B2 (en) * | 2002-06-27 | 2005-09-13 | Nektar Therapeutics | Apparatus and method for filling a receptacle with powder |
| US7284553B2 (en) * | 2002-12-12 | 2007-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
| US6941954B1 (en) * | 2003-02-20 | 2005-09-13 | Michele Belcher | Fingernail protection device |
| DE10352277A1 (de) * | 2003-11-08 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
-
1998
- 1998-08-05 DE DE19835346A patent/DE19835346A1/de not_active Withdrawn
-
1999
- 1999-03-08 UA UA2001031523A patent/UA71920C2/uk unknown
- 1999-08-03 IL IL14112499A patent/IL141124A0/xx active IP Right Grant
- 1999-08-03 PT PT99944325T patent/PT1100474E/pt unknown
- 1999-08-03 ID IDW20010274A patent/ID28290A/id unknown
- 1999-08-03 EA EA200100176A patent/EA002186B1/ru not_active IP Right Cessation
- 1999-08-03 CN CNB998092657A patent/CN1151779C/zh not_active Expired - Lifetime
- 1999-08-03 EP EP99944325A patent/EP1100474B1/de not_active Expired - Lifetime
- 1999-08-03 BR BR9912748-2A patent/BR9912748A/pt not_active Application Discontinuation
- 1999-08-03 DK DK99944325T patent/DK1100474T5/da active
- 1999-08-03 TR TR2001/00355T patent/TR200100355T2/xx unknown
- 1999-08-03 YU YU5401A patent/YU49388B/sh unknown
- 1999-08-03 UY UY25637A patent/UY25637A1/es not_active IP Right Cessation
- 1999-08-03 WO PCT/EP1999/005614 patent/WO2000007572A2/de active IP Right Grant
- 1999-08-03 CZ CZ20010444A patent/CZ301558B6/cs not_active IP Right Cessation
- 1999-08-03 AT AT99944325T patent/ATE220542T1/de active
- 1999-08-03 PL PL346168A patent/PL191231B1/pl unknown
- 1999-08-03 AR ARP990103868A patent/AR023640A1/es active Pending
- 1999-08-03 EE EEP200100073A patent/EE04451B1/xx not_active IP Right Cessation
- 1999-08-03 CA CA002338323A patent/CA2338323C/en not_active Expired - Lifetime
- 1999-08-03 HU HU0103490A patent/HU224955B1/hu unknown
- 1999-08-03 DE DE59902055T patent/DE59902055D1/de not_active Expired - Lifetime
- 1999-08-03 TW TW088113240A patent/TWI221420B/zh not_active IP Right Cessation
- 1999-08-03 SI SI9930089T patent/SI1100474T1/xx unknown
- 1999-08-03 ES ES99944325T patent/ES2180325T3/es not_active Expired - Lifetime
- 1999-08-03 SK SK169-2001A patent/SK283568B6/sk not_active IP Right Cessation
- 1999-08-03 NZ NZ509977A patent/NZ509977A/en not_active IP Right Cessation
- 1999-08-03 AU AU57304/99A patent/AU763266B2/en not_active Expired
- 1999-08-03 KR KR1020017001462A patent/KR100622291B1/ko not_active IP Right Cessation
- 1999-08-03 JP JP2000563258A patent/JP2002522378A/ja active Pending
- 1999-08-04 MY MYPI99003330A patent/MY117930A/en unknown
-
2001
- 2001-01-26 IL IL141124A patent/IL141124A/en not_active IP Right Cessation
- 2001-01-26 BG BG105189A patent/BG64115B1/bg active Active
- 2001-01-29 ZA ZA200100796A patent/ZA200100796B/en unknown
- 2001-01-31 NO NO20010535A patent/NO329078B1/no not_active IP Right Cessation
- 2001-03-07 US US09/800,647 patent/US20010008637A1/en not_active Abandoned
- 2001-12-19 HK HK01108874A patent/HK1037975A1/xx not_active IP Right Cessation
-
2003
- 2003-12-18 US US10/740,225 patent/US20040131668A1/en not_active Abandoned
-
2008
- 2008-01-08 US US11/970,982 patent/US8298575B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA71920C2 (en) | Two-part capsule for receiving pharmaceutical preparations for powder inhalers | |
| RU2319512C2 (ru) | Кассета и ингалятор для порошкового фармацевтического препарата (варианты) | |
| JP3535178B2 (ja) | 噴射剤のない計量エアゾル用２チャンバカートリッジ | |
| US20140183070A1 (en) | Device for Disposing Medicament Products | |
| CA3061917C (en) | System for dosing and dispensing medication | |
| US20200369454A1 (en) | Container and method for reconstitution of substances | |
| US7703620B2 (en) | Chain linked capsules | |
| MXPA01001312A (en) | Two-piece capsule for receiving pharmaceutical preparations for powder inhalers | |
| KR100483220B1 (ko) | 분사제없이에어로졸을계량투여하기위한2챔버카트리지,용기용밀폐캡및미니정제 |